Sections & Products

Main > A1. CORP. INDEX. Nn-Nz > Novartis /P C2

This data is not available for free

Novartis /P C2's subsections

2000. 05.22.2000. (Agriculture)

2001. 01.22.2001. (Genomics Deal)

2001. 03.05.2001. (Natural Prodt.)

2001. 04.02.2001. (Parent of)

2001. 05.08.2001. (Allergy/Asthma)

2001. 09.19.2001. (Cyclosporin)

2001. 11.17.2001. (Parent of)

2002. 03.20.2002. (IBS)

2002. 11.04.2002. (Parent of)

2002. 12.02.2002. (Historics)

2003. 01.27.2003. (Roche)

2003. 03.17.2003. (Ranking)

2003. 03.18.2003. (Executive)

2003. 03.18.2003. (Urology)

2003. 04.21.2003. (Ophthalmology)

2003. 06.22.2003. (Allergy/Asthma)

2004. 08.23.2004. (Singapore Base)

2004. 11.22.2004. (Natural Prodt.)

2004. 12.13.2004. (COX-2 Inhibitor)

2005. 01.10.2005. (Infinity Deal)

2005. 02.07.2005. (Diabetes)

2005. 06.06.2005. (Acq.: Hexal)

2005. 06.06.2005. (Anadys Pharma.)

2005. 06.06.2005. (Hybridon Inc)

2005. 06.06.2005. (MorphoChem AG)

2005. 06.13.2005. (InnoCentive)

2005. 08.29.2005. (Bladder Cancer)

2005. 09.05.2005. (Chiral Catalysi)

2005. 09.05.2005. (SFC>CSP>Anal.)

2005. 09.12.2005. (RNAi Drugs)

2005. 10.24.2005. (Malaria)

2006. 01.09.2006. (Oncology)

2006. 02.06.2006. (India Patent)

2006. 02.27.2006. (Alnylam)

2006. 02.27.2006. (Singapore)

2006. 11.13.2006. (CN>R&D)

2006. 12.06.2006. (Diabetes)

2007. 04.09.2007. US Clinical Dev

2007. 06.18.2007. Research Manager

2007. 08.13.2007. (Head Corp R&D)

2007. 08.18.2007. (Osteoporosis)

2007. 09.06.2007. (Antibiotics)

2007. 10.08.2007. Head Global Tech

2007. 12.02.2007. (MorphoSys)

2007. 12.03.2007. (Cardio.>HyperT.)

2008. 01.18.2007. (Depression)

2008. 02.01.2008. (Diabetes)

2008. 02.25.2008. (Diabetes)

2008. 02.28.2008. (Oncology)

2008. 03.03.2008. Head Corp. Resear

2008. 03.10.2008. (Oncology)

2008. 03.31.2008. (Cardiology)

2008. 04.07.2008. (Alcon)

2008. 04.08.2008. (Inflammation)

2008. 04.11.2008. (Oncology)

2008. 04.11.2008. (Osteoporosis)

2008. 04.14.2008. (Alcon)

2008. 04.15.2008. (Neuro>Parkinson)

2008. 04.28.2008. (Diabetes)

2008. 04.28.2008. (Ophthalmology)

2008. 05.14.2008. (Cardio.HyperT.)

2008. 10.27.2008. (COO)

2008. 10.27.2008. (Inhal. Deliv.)

2008. 12.01.2008. NA Pharma Bus.

2009. 03.30.2009. Novartis India

2009. 04.30.2009. (Cardio.>HyperT.)

2009. 05.11.2009. Global Discovery

2009. 08.06.2009. Onco.>Kidney C

2009. 08.17.2009. Neuro>MS>IFN Beta

2009. 10.08.2009. Antibiotics

2010. 02.09.2010. Hepato.>HCV

2010. 06.17.2010. Onco.>CML

2010. 10.11.2010. Onco.>Advd. NET

2010. 11.03.2010. Onco.>Brain C.

2010. 12.09.2010. Onco.>Breast C.+T

2010. 12.20.2010. Russia

2011. 02.09.2011. Onco.>Pancreas C

2011. 04.11.2011. Onco.>PI3K Inh.

2012. 02.01.2012. Onco.>GIST

2012. 02.17.2012. Cardio.>HyperT.

2012. 04.26.2012. Onco.>RA+TSC

2012. 08.06.2012. Onco.>Uni. Penn.

2012. 08.15.2012. Ophthalmo.>VMA

2012. 08.26. CV.>Chronic HF-PEF

2012. 08.28.2012. Onco.>MF

2012. 09.05.2012. Pneumo.>CF>TIP

2012. 09.21.2012. Diabetes

2012. 10.01.2012. Pneumo.>COPD G

2012. 10.31.2012. SG BioTech Mfg.

2012. 11.08.2012. R&D Pipeline

2012. 11.20.2012. Influenza Vacc.

2012. 12.15.2012. Cushings Disease

2013. 01.10.2013. Onco.>NCKT>RA>TSC

2013. 01.16.2013. Onco.>Breast C.+E

2013. 01.23.2013. Hema.>NTDT

2013. 02.15.2013. Liver>Transplant

2013. 03.01.2013. Gouty Arthritis

2013. 04.01.2013. IN Patent

2013. 04.19.2013. Ophthalmo.>Glauco

2013. 04.22. Onco.>Melanoma>LGX818

2013. 04.25. Malaria

2013. 05.10. Rheuma.>SJIA

2013. 06.02. Onco.>Breast C.+T+V

2013. 06.24. Derma.>Psoriasis>Bio

2013. 06.27. Neuro.>AD

2013. 07.08. Biological E Ltd.

2013. 08.01. Meningococcal Vac

2013. 08.07. Onco.>Liver C.

2013. 08.20. Muscle>sIBM

2013. 09.06. Cell Therapy Kidney Tr

2013. 10.04. Neuro.>MS>Fingo.

2013. 10.05. Derma.>CSU

2013. 11.11. Blood Transfusion Diag

2013. 11.14. H7N9 Avian Flu Vacc.

2013. 11.22. Share BuyBack..

2013. 12.09. Onco.>CML>Ph+ CML

2014. 01.13. Pneumo.>COPD G+I

2014. 02.17. Onco.>ImmunoTherapy

2014. 02.26. Clin. Trial Data Trans

2014. 03.07. Onco.>PV

2014. 03.21. Derma.>CIU

2014. 03.31. CV.>Chronic HF-REF

2014. 04.03. Onco.>AACR

2014. 04.09. Alcon Appoints

2014. 04.25. Pneumo.>COPD I

2014. 04.29. Onco.>ALK+ NSCLC

2014. 05.05. Endo.>Acromegaly

2014. 05.16. CV.>Acute HF

2014. 05.19. Ophthalmo.>Wet AMD

2014. 06.01. Onco.>Basal Cell C.

2014. 06.01. Onco.>Pres.

2014. 07.15. Alcon & Google

2014. 07.15. Neuro.>AD>Banner

2014. 07.24. Biosimilar Filgrastim

2014. 07.30. Malaria

2014. 08.20. TB Alliance

2014. 09.25. Psoriatic Arthritis

2014. 09.27. Onco.>ALL>CTL019

2014. 09.27. Onco.>Pancreas C.

2014. 10.26. Flu Vacc Bus Sale To

2014. 12.01. Neuro.>PPMS>Fingo.

2014. 12.16. Endo.>Acromegaly

2015. 01.12. Qualcomm

2015. 01.21. Derma.>Psoriasis

2015. 01.23. Meningitis Vacc.

2015. 02.23. Onco.>MM

2015. 03.06. BioSimilar Filgrastim

2015. 03.30. Aduro Biotech

2015. 03.30. Fe Overload

2015. 06.12. Blood Dis.>Chronic ITP

2015. 06.29. Acq. Spinifex Pharma

2015. 07.08. CV.>HF

2015. 07.24. Onco.>Skin>laBCC

2015. 09.01. Neurology Amgen

2015. 09.03. Filgrastim-sndz

2015. 10.21. Acq. Admune Therap.

2015. 10.29. Pneumo.>COPD I+G

2015. 11.20. Onco.>Melanoma

2016. 01.11. Surface Oncology

2016. 01.15. Rheuma.>As & PsA

2016. 02.09. CV.>HF Cigna Aetna

2016. 02.12. Infliximab BioSimilar

2016. 02.26. Onco.>GI NET; Lung NET

2016. 06.15. Malaria

2016. 06.28. Xencor

2016. 07.07. Pneumo.>Asthma

2016. 08.02. Alcon>Glaucoma

2016. 09.23. Periodic Fever Syndrom

2016. 11.21. Acq. Selexys Pharma.

2016. 12.19. Liver Dis.>Conatus

2017. 04.06. Lubris LLC.

2017. 04.28. Onco.>AML &

2017. 06.05. Onco.>Breast C.>IBM

2017. 06.19. BioSimilar RituxiMAb

2017. 06.23. Onco.>NSCLC

2017. 07.13. Onco.>ALL>CTL019

2017. 08.21. Malaria

2017. 08.24. Onco.>Breast C.

2017. 08.30. Onco.>ALL>CTL019

2017. 09.28. UC Berkeley

2017. 11.13. Homology Medicines

2018. 01.24. Ophthalmo.>Gene

2018. 02.14. Infectious Diarrheal

2018. 03.20. Harvard

2018. 03.27. Consumer Healthcare

2018. 04.17. Malaria

2018. 06.29. Plan Alcon Spin-Off

2018. 07.18. Onco.>Breast C.

2018. 10.29. Hepato.>NASH>Pfizer

2019. 03.27. Neuro.>MS>Sipon

2019. 04.01. IFM Thera.>IFM Tre

2019. 05.24. Neuro.>SMA.>USA>OK

2019. 05.24. Onco.>Breast C.

2019. 10.08. Ophthalmo.>Wet AMD

2019. 11.15. Sickle Cell DIS.>Pain

2019. 11.24. Acq. Medicines Company

2020. 03.03. Neuro.>SPMS>CA>OK

2020. 04.02. COVID-19 Treat.

2020. 06.16. AOSD>USA>FDA>OK

2020. 06.17. Rheuma.>nr-axSpA

2020. 08.13. Onco.>Breast C.>CA>OK

2020. 08.20. Neuro.>RMS>USA>OK

2020. 10.28. COVID-19 Molecular Par

2020. 12.16. Neuro.>SMA.>CA>OK

2020. 12.17. Acq. Cadent Therapeuti

2021. 01.11. Onco.>BeiGene

2021. 06.01. Derma.>FDA Approval

2021. 09.21. Ophthalmo.>Patent

2021. 12.22. Acq. Gyroscope Therap.

2021. 12.22. Cardio.>HeFH>USA>OK

2022. 03.08. Voyager Therapeutics

2022. 03.23. Onco.>Prostate C.

2022. 04.06. Rare DISs.>PROS>USA>OK

2022. 05.28. Onco.>FL>USA>OK

2022. 06.22. Onco.>NSCLC>EU>OK

2022. 06.23. Onco.>Solid>USA>OK

2022. 06.30. Acq. Kedalion Therapeu

2023. 06.12. Acq. Chinook Therapeut

2023. 07.17. Acq. by Novartis

2023. 09.05. Sandoz Spin-Off

2023. 10.31. Derma.>HS>USA>OK

2023. 12.06. Hemato.>PNH>USA>OK

2024. 01.07. Acq. Calypso Biotech!

2024. 02.05. Acq. Morphosys AG

Chiron Diagnostics/P

Friedrich Miescher Institute/P

Genetic Therapy Inc./P

Genomics Institute/P

Genomics Novartis Foundation C2

Institute Genomic Research/P

Novartis AG/P

Novartis Animal Health/P C2

Novartis Consumer Health/P C2

Novartis Corp./P

Novartis Diagnostics/P C2

Novartis Finance/P

Novartis ForschungsStiftung/P

Novartis Institute For Tropical C2

Novartis Institutes BioMedical C2

Novartis Intl. Pharmaceutical/P

Novartis Pharma GmbH/P C2

Novartis Pharmaceuticals Corp./P C2

Novartis Vaccines/P C2

Novartis Venture Funds C2

Novatis AG/P

Pharma>Ophthalmics C2

Sandoz Pharm. Corp./P

Sandoz Pharmaceuticals Corp./P

Web-Site

Z - OK

Novartis /P C2's products
This section has no products